脑死亡/神经学标准死亡的判定:世界脑死亡项目
该共识由国际多学科专家组基于文献综述和专家意见制定,旨在统一脑死亡/神经学标准死亡(BD/DNC)的概念、标准和实践。推荐在判定前确立可导致全脑功能完全且不可逆丧失的神经学诊断,并排除可能干扰临床检查或模拟BD/DNC的疾病。BD/DNC的判定可通过临床检查证实昏迷、脑干反射消失和呼吸暂停,具体包括对最大外部刺激无觉醒反应、瞳孔固定且无光反射、角膜/头眼/前庭眼反射消失、无面部运动、咽反射消失、咳嗽反射消失、肢体无脑介导运动反应,以及呼吸暂停试验达到pH<7.30且PaCO2≥60 mm Hg时无自主呼吸。若临床检查无法完成,可考虑辅助检查如血流研究或电生理测试。儿童、接受ECMO或治疗性低温的患者需特殊考虑。
要点
- 判定BD/DNC前必须确立可导致全脑功能完全且不可逆丧失的神经学诊断,并排除混杂因素和模拟疾病。
- 临床检查需证实昏迷、脑干反射消失和呼吸暂停:对最大外部刺激无觉醒反应、瞳孔固定无光反射、角膜/头眼/前庭眼反射消失、无面部运动、咽反射消失、咳嗽反射消失、肢体无脑介导运动反应。
- 呼吸暂停试验目标为pH<7.30且PaCO2≥60 mm Hg时无自主呼吸。
- 若临床检查无法完成,可考虑辅助检查如血流研究或电生理测试。
- 儿童、接受ECMO或治疗性低温的患者需特殊考虑,并需关注宗教、社会文化、法律和资源因素。
适用人群与场景
- 成人及儿童疑似脑死亡/神经学标准死亡的患者。
- 接受ECMO或治疗性低温的患者需特殊考虑。
诊断标准与关键阈值
- BD/DNC的临床检查标准:昏迷(对最大外部刺激包括有害视觉、听觉和触觉刺激无觉醒或意识证据);瞳孔固定于中位或散大且对光无反应;角膜、头眼和前庭眼反射消失;对有害刺激无面部运动;双侧后咽部刺激无咽反射;深部气管吸引无咳嗽反射;肢体有害刺激无脑介导运动反应;呼吸暂停试验达到pH<7.30且PaCO2≥60 mm Hg时无自主呼吸。
处置流程与药物剂量
- 第一步:确立可导致全脑功能完全且不可逆丧失的神经学诊断。
- 第二步:排除可能干扰临床检查的疾病和可能模拟BD/DNC的疾病。
- 第三步:进行临床检查证实昏迷、脑干反射消失和呼吸暂停,具体标准见诊断标准。
- 若临床检查无法完成,可考虑辅助检查如血流研究或电生理测试。
- 儿童、接受ECMO或治疗性低温的患者需特殊考虑。
研究设计与关键结果
- 该共识基于1992年1月1日至2020年4月的Cochrane、Embase和MEDLINE数据库文献检索,以及大型国际多学科专家组的共识制定。
- 由于缺乏随机临床试验或大型观察性研究的高质量数据,推荐基于贡献者和代表相关学科(包括重症监护、神经病学和神经外科)的医学学会的共识。
证据类型、等级与局限
- 证据类型:国际多学科专家共识声明,基于文献综述和专家意见。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该共识提供了成人及儿童BD/DNC判定的最低临床标准,可指导专业学会和国家修订或制定方案和程序,促进国内和国际间的一致性。
- 临床医生在判定BD/DNC时应遵循上述最低标准,并注意特殊人群(儿童、ECMO、治疗性低温)和宗教、社会文化、法律及资源因素。
指南或共识出处
- 世界脑死亡项目(World Brain Death Project)共识声明,发表于JAMA。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: There are inconsistencies in concept, criteria, practice, and documentation of brain death/death by neurologic criteria (BD/DNC) both internationally and within countries.
OBJECTIVE: To formulate a consensus statement of recommendations on determination of BD/DNC based on review of the literature and expert opinion of a large multidisciplinary, international panel.
PROCESS: Relevant international professional societies were recruited to develop recommendations regarding determination of BD/DNC. Literature searches of the Cochrane, Embase, and MEDLINE databases included January 1, 1992, through April 2020 identified pertinent articles for review. Because of the lack of high-quality data from randomized clinical trials or large observational studies, recommendations were formulated based on consensus of contributors and medical societies that represented relevant disciplines, including critical care, neurology, and neurosurgery.
EVIDENCE SYNTHESIS: Based on review of the literature and consensus from a large multidisciplinary, international panel, minimum clinical criteria needed to determine BD/DNC in various circumstances were developed.
RECOMMENDATIONS: Prior to evaluating a patient for BD/DNC, the patient should have an established neurologic diagnosis that can lead to the complete and irreversible loss of all brain function, and conditions that may confound the clinical examination and diseases that may mimic BD/DNC should be excluded. Determination of BD/DNC can be done with a clinical examination that demonstrates coma, brainstem areflexia, and apnea. This is seen when (1) there is no evidence of arousal or awareness to maximal external stimulation, including noxious visual, auditory, and tactile stimulation; (2) pupils are fixed in a midsize or dilated position and are nonreactive to light; (3) corneal, oculocephalic, and oculovestibular reflexes are absent; (4) there is no facial movement to noxious stimulation; (5) the gag reflex is absent to bilateral posterior pharyngeal stimulation; (6) the cough reflex is absent to deep tracheal suctioning; (7) there is no brain-mediated motor response to noxious stimulation of the limbs; and (8) spontaneous respirations are not observed when apnea test targets reach pH <7.30 and Paco2 ≥60 mm Hg. If the clinical examination cannot be completed, ancillary testing may be considered with blood flow studies or electrophysiologic testing. Special consideration is needed for children, for persons receiving extracorporeal membrane oxygenation, and for those receiving therapeutic hypothermia, as well as for factors such as religious, societal, and cultural perspectives; legal requirements; and resource availability.
CONCLUSIONS AND RELEVANCE: This report provides recommendations for the minimum clinical standards for determination of brain death/death by neurologic criteria in adults and children with clear guidance for various clinical circumstances. The recommendations have widespread international society endorsement and can serve to guide professional societies and countries in the revision or development of protocols and procedures for determination of brain death/death by neurologic criteria, leading to greater consistency within and between countries.
参考来源
- Greer DM, Shemie SD, Lewis A, et al. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA. 2020. PMID: 32761206. doi:10.1001/jama.2020.11586
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。